ARCHIVES

“Unfortunate Result Of Burzynski’s Practice Over Two Decades: Thousands Of Patients, Not Enough Data” To Determine Safety, Efficacy, FDA Says

This article is from The Cancer Letter archive.

Vol. 24 No. 36 | September 25, 1998

Download PDF Visit The Full Archive

Related Articles

AACR 2014 Cancer Progress Report: More Federal Funds Needed

September 19, 2014

In Brief: Hellman To Head DCT board; Gard Joins Colorado Group; NCI May Support Death Index

September 12, 1980

In Brief: Increased Output Can Hold Down High Let Cost, Kligerman says; No More Groups On The Block

March 18, 1977

Medical Advances Not Driven Entirely By Science, Author Physician Barron Lerner Tells Journalists

March 22, 2002

NCI Proposal Would Give Drug Sponsors Commercial Rights To Biomarker Inventions

October 16, 2009

Three cancer centers joined the Multiple Myeloma Research Consortium.

September 16, 2005